We are live on
!
Find out more
ARK Genomic Revolution ETF
ARKG
ARKG
218 hedge funds and large institutions have $743M invested in ARK Genomic Revolution ETF in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
9% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 55
0.32% less ownership
Funds ownership: 72.38% → 72.06% (-0.32%)
8% less funds holding
Funds holding: 238 → 218 (-20)
13% less capital invested
Capital invested by funds: $854M → $743M (-$111M)
26% less call options, than puts
Call options by funds: $79.9M | Put options by funds: $108M
28% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 39
Holders
218
Holders Change
-20
Holders Change %
-8.4%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
60
Reduced
55
Closed
39
Calls
$79.9M
Puts
$108M
Net Calls
-$28.1M
Net Calls Change
+$211M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$61M |
| 2 |
Goldman Sachs
New York
|
+$25M |
| 3 |
Morgan Stanley
New York
|
+$24.3M |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$22M |
| 5 |
HI
Humankind Investments
New York
|
+$11.3M |
Top Sellers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$59.2M |
| 2 |
Citigroup
New York
|
-$27.3M |
| 3 |
Jane Street
New York
|
-$14.2M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$11.8M |
